Skip to main content
. 2023 Jul 14;12(7):1506–1516. doi: 10.21037/tlcr-23-7

Figure 2.

Figure 2

Kaplan-Meier curves for OS stratified based on aberrant laboratory parameters at baseline and early treatment period in patients with non-small cell lung cancer undergoing immunotherapy only. Strata 1, 2, 3, and 4 indicate baseline physiological and early treatment period physiological, baseline physiological and early treatment period aberrant, baseline aberrant and early treatment period physiological, and baseline aberrant laboratory parameter and early treatment period aberrant laboratory parameter respectively. (A) Kaplan-Meier curves of OS stratified based on aberrant NLR at baseline and early treatment period; (B) Kaplan-Meier curves of OS stratified based on aberrant CRP at baseline and early treatment period; (C) Kaplan-Meier curves of OS stratified based on aberrant LDH at baseline and early treatment period. NLR, neutrophil-lymphocyte ratio; CRP, C-reactive protein, LDH, lactate dehydrogenase; OS, overall survival.